Conditions:
- Acute myocardial infarction
- Acute coronary syndrome
- Cardiovascular disease
- Congestive heart failure
- Acute decompensated heart failure
- Coronary artery disease
- Hypertension
- Acute cardiogenic pulmonary edema
- Heart failure
Therapeutic Approaches:
- Cell therapies
- Devices
- Drugs including:
- Diuretics
- Thrombolytics
Some Recent Assignments and Achievements:
Phase I Pharmacokinetic study of thromboxane antagonist
Phase I First in man – with a new class of drug in heart failure
Phase II Acute myocardial infarction
Phase II Acute coronary syndromes
Phase II Acute coronary syndrome
Phase II Congestive heart failure (stem cell study)
Phase II Acute decompensated heart failure
Phase II Acute myocardial infarction
Phase II Acute coronary syndrome
Phase II Cardiovascular disease
Phase II Two studies with a surgical device in Heart failure (NYHA III-NYHA IV patients)
Phase III Coronary artery disease
Phase III Hypertension (renal function in elderly patients)
Phase III Hypertension (investigation of plasma lipids)
Phase III Hypertension (pulmonary hypertension)
Phase III Hypertension (left ventricular hypertrophy)
Phase III Acute cardiogenic pulmonary edema
Phase III Cardiac failure
Phase III Acute myocardial infarction
Phase III Coronary Artery Disease
Phase III Global study in hypertension
Phase III Global study in Heart Failure
Phase III Global study in Heart Failure with device – responsibility for 6 countries and 40% of the patients
Phase IV Cardiac failure (patient acceptability in general practice)
Phase IV Cardiac failure (comparison of 2 different diuretics)
